First-line use of calcipotriene/betamethasone dipropionate combination products for the treatment of plaque psoriasis is associated with lower health care utilization and cost
Abstract
Authors
S.R. Feldman E. Levi P. Pathak S. Kakatkar R. Blakrishnan